Apogee Therapeutics, Inc. · NASDAQ:APGE

Dambkowski Carl sold 5,500 Apogee Therapeutics, Inc. shares (Form 4)

Traded Jul 1, 2026 · Filed Jul 2, 2026

On Jul 1, 2026, Dambkowski Carl (Chief Medical Officer) sold 5,500 Apogee Therapeutics, Inc. shares at US$132.74 for US$730K under a trading plan, leaving 177,873 shares. Filed Jul 2, 2026 (Form 4).

Sold
5,500 shares
Price
US$132.74
Value
US$730K
Holding after
177,873 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Medical Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 1, 2026Common StockOption exercise4,125US$22.86183,373Direct
Jul 1, 2026Common StockSale5,500US$132.74177,873Direct

Source

View original at SEC

Related